PEOPLE - VIVUS (US) makes appointments:
This article was originally published in Clinica
Executive Summary
Mark Logan and Mario Rosati have been appointed to the board of directors at VIVUS, the US developer of the MUSE system for erectile dysfunction. Mr Logan is currently chairman, president and CEO of ophthalmology company VISX and Mr Rosati is a partner at law firm Wilson, Sonsini, Goodrich & Rosati.